WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Blake BorgesonDirector2026-11-0340,000$3.88
$155.20kSell
Blake BorgesonDirector2026-10-0650,000$4.84
$242.00kSell
Robert HershbergDirector2026-10-0625,000$2.22
$55.50kBuy
Robert HershbergDirector2026-10-0625,000$5.00
$125.00kSell
Ben R. TaylorCFO2026-09-155,396$3.41
$18.40kSell
Najat KhanCEO;Pres2026-09-0822,408$3.52
$78.83kSell
Blake BorgesonDirector2026-09-0130,000$3.34
$100.20kSell
Najat KhanCEO;Pres2026-08-1780,498$3.16
$254.37kSell
David HallettCSci2026-08-1726,657$3.16
$84.24kSell
Ben R. TaylorCFO2026-08-1725,018$3.16
$79.06kSell

1 of 6

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lux Ventures IV LP4.87%30,308,614$107.60MInsider
Dean Y. Li1.79%11,167,732$39.65MInsider
Investment Co Pjsc Mubadala1.13%7,062,869$25.07MInsider
Blake Borgeson0.97%6,068,287$21.54MInsider
Zachary Bogue0.60%3,736,341$13.26MInsider
Data Collective IV LP0.60%3,726,963$13.23MInsider
Najat Khan0.33%2,072,890$7.36MInsider
Michael Secora0.24%1,487,694$5.28MInsider
MIC Capital Partners Public Us IM LLC0.22%1,388,889$4.93MInsider
MIC Capital Partners Public Parallel Cayman LP0.22%1,388,889$4.93MInsider

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX0.06%11.88%Net SellingNet Selling
REPL0.10%44.56%Net SellingNet Buying
IMNM0.10%3.90%Net SellingNet Selling
LKFT0.05%0.00%
TRAX0.08%20.36%Net SellingNet Buying
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 0.06% institutional shareholders, 11.88% Recursion Pharmaceuticals insiders, and 88.06% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 4.87% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $107.60M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.